Mécanismes des hyperlipidémies dues aux immunosuppresseurs: Dyslipidaemia and its Management after Immunosuppressive Treatment

Author： Yann Gueguen Yann Gueguen est le récipiendaire d’une bourse de la Région Lorraine.   Ferrari Luc   Batt Anne-Marie  

Publisher： Adis International

ISSN： 0040-5957

Source： Therapie, Vol.59, Iss.4, 2004-01, pp. : 463-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarqueurs et étude pharmacocinétique-pharmacodynamique des immunosuppresseurs: Biomarkers and Pharmacokinetic-Pharmacodynamic Studies of Immunosuppressive Agents

By Paintaud Gilles   Bénéton Maud   Watier Hervé  

Therapie, Vol. 59, Iss. 2, 2004-01 ,pp. : 179-183

Adis International

Access to resources Recommend Favorite

La cardiotoxicité des anthracyclines : mécanismes et cibles pharmacologiques de prévention: Molecular Mechanisms of Anthracycline-Induced Cardiotoxicity and its Prevention

By Andrieu-Abadie Nathalie  

Therapie, Vol. 59, Iss. 1, 2004-01 ,pp. : 121-126

Adis International

Access to resources Recommend Favorite

Immunosuppressive Treatment of Ocular Myasthenia Gravis

By Tackenberg B.   Hemmer B.   Oertel W.H.   Sommer N.  

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Mécanismes d’action des statines et des fibrates: Mechanism of Action of Statins and Fibrates

By Duriez Patrick  

Therapie, Vol. 58, Iss. 1, 2003-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite

Fish Oil Treatment of Interferon-Alpha-Induced Dyslipidaemia: Study in Patients with Chronic Hepatitis C

By Malaguarnera M.   Restuccia N.   Fazio I.D.   Panebianco M.P.   Gulizia G.   Giugno I.  

BioDrugs, Vol. 11, Iss. 4, 1999-04 ,pp. : 285-291

Adis International

Access to resources Recommend Favorite